Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Department of Health has today announced four million pounds to improve the evidence for new diagnostic tests, benefiting patient care. The National Institute for Health Research (NIHR) will share the funding across four NHS organisations, including Oxford.

Every year over 16 million diagnostic tests are carried out across the NHS. This money will fund research that looks at the way a number of different diseases are diagnosed, so patients can access the best available treatments more quickly.

The National Institute for Health Research (NIHR) will share the funding across four NHS organisations in London, Leeds, Newcastle and Oxford. These places will become national centres of expertise called NIHR Diagnostic Evidence Co-operatives.

Dr Matthew Thompson, Director of Oxford Centre for Monitoring and Diagnosis, Department of Primary Care Health Sciences, University of Oxford commented: "We are delighted that the NIHR has selected Oxford as the site that will pioneer research and development into new diagnostic tests in primary care. Together with our partners, which include Oxford Health NHS Foundation Trust, we will bring together the diagnostics industry, frontline clinicians, and researchers to produce new evidence to show which new tests should be used in the NHS. The funding announced by the NIHR will position our Centre as a national resource for diagnostic testing in NHS primary care."

 

Read more

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.